Viewing Study NCT02431351

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:51 PM
Ignite Modification Date: 2026-02-25 @ 12:56 AM
Study NCT ID: NCT02431351
Status: WITHDRAWN
Last Update Posted: 2023-01-26
First Post: 2015-04-27
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Efficacy & Safety Study of KPT-330 in Erythropoietin-Refractory Lower-Risk Myelodysplastic Syndrome Patients
Sponsor: Karyopharm Therapeutics Inc
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Myelodysplastic Syndrome View
Keywords:

Keywords

Keyword Brief Keyword Text View
None KPT-330 View
None Karyopharm View
None Selinexor View
None SIER View
None Myelodysplastic Syndrome (MDS) View
None Erythropoietin (EPO) View
None Refractory View